2 February 2025

New opioids free Pain reliever It was approved by the US Food and Drug Administration (FDA) on Thursday, which represents a non -compressed alternative to patients.

Journalvx (suzetrigine), made by Vertex, is “a non -Ophthalmic oral pain signal inhibitor,” according to a journalist from Massachusetts -based company.

The new medication for the treatment of moderate to severe acute pain aims in adults.

The study indicates that the common pain reliever can cause medical complications in some people over the age of 65

The importance of a non -opium alternative

Patients with acute pain are often prescribed after surgery, bone fracture or injury Oidic drugsAccording to Juli Ptaybat, PhD, PhD, Banner Neurosurgery – University Medicine and Head of the Department of Neurosurgery at the School of Medicine at Arizona University in Toxon.

A woman carrying pill

A new pain -free pain is approved by the Food and Drug Administration on Thursday, which represents an uncompromising alternative to patients. (Istock)

“This is the first time that many patients have received opioids, and it is known that a sub -group of patients Accreditation or addict She told Fox News Digital.

“Pain with pain had very few options to treat their pain with drugs that do not have the properties of addiction or side effects that they could not tolerate.”

Types of the six most common headaches – and when do you see a doctor

Bachis pointed out that the main reason behind the presence of traditional pain properties has addiction or unbearable side effects that they work by modifying receptors in the brain.

“This medicine – a drug that prevents sodium channels – works outside the brain on pain receptors.”

“That you have a non-opium option to describe in these cases exciting-and this is the first time for nearly two decades. We have something new to offer it patients to severe pain.”

“The main unparalleled need”

Acute pain – sudden or urgent pain resulting from injury, shock or surgery – affects more than 80 million Americans annually and is the most common cause Emergency Department Visits, according to statistics.

About half of these opiums will be prescribed, and 10 % of these will be “long use of aids”.

An elderly woman with knee pain sitting on a chair

Acute pain – sudden or urgent pain that results from injury, shock or surgery – affects more than 80 million Americans annually and is the most common cause of emergency department visits. (Istock)

In 2023, more than five million Americans were 12 or greater than “the disorder of using medical prescriptions” during the past year, according to the CDC and Prevention Centers (CDC).

About 294,000 people died Opium prescription is excessive doses Between 1999 and 2022, the source above stated.

By effectively managing acute pain, suzetrigine may help prevent it from developing to chronic pain without the risk of dependency, and to meet a “great, unparalleled need”.

“This is the first time for nearly two decades. We have something new to give patients to severe pain.”

“Many current treatments depend on opiates, which contributes to dependency and abuse,” he told Fox News Digital. The non -opioid Suzetrigine mechanism eliminates the risks of misuse and addiction Respiratory depressionThis makes it a safer alternative to acute pain management. “

In addition to acute pain, suzetrigine may also be a solution for nerve pain (nerve), depending on the results of more studies, the doctor added.

The doctor treats the shoulder's shoulder pain

In addition to acute pain, suzetrigine may also be a solution for nerve pain (nerve), depending on the results of more studies, as the doctor indicated. (Istock)

Dr. Mark Sagel, Professor of Clinical Medicine at New York University, Langon Health and Okbar News, also praised the approval of Suzitrgen.

Click here to get the Fox News app

“She has There is no sign of addiction“This makes it a very important new tool and we are fighting the opioid epidemic,” Fox News Digital said.

In clinical trials, non -opioid drugs have received high satisfaction assessments of patients, with 83 % of reporting of “good” to relieve “excellent” pain in realistic applications, Cheng noted.

“This drug is a big step forward and it has been well studied.”

Siegel pointed out that the drug showed that it reduces the pain in about half, which he described as “excellent”.

“This drug is a big step forward and it was well studied,” he added.

Access and side effects

Suzetrigine has become available to patients with Acute painFamous.

“It will be important to find comfortable doctors in prescribing pain medications and checking your insurance company to ensure its coverage,” I advised.

Click here to register in our health newsletter

The drug is expected to fall into the absence of philosophys that prevent the nation's addiction (NOPAIN), a consideration from January 2025, which provides coverage of medical care for non -opioid pain treatments adopted by FDA, according to Sing.

“This policy aims to improve access to costs, and ensure the inclusion of suzetrigine in outpatient clinics Surgical settings With reducing dependence on opiates. ”

Pain reliever

In 2023, more than five million Americans were 12 or greater than the “recipes use disorder” during the past year, for each center of disease control. (Istock)

The most common side effects of JournaVX, according to the company's location, itching, muscle spasms, rashes, and increased enzyme levels called creatine phosphocinase in the blood, among other things.

The drug may also cause temporary fertility challenges.

For more health articles, visit www.foxnews.com/health

The company has warned, and some medications can also increase the risk of side effects and affect the effectiveness of the drug, and can also be food or drink that contains grapefruit.

Patients should see their doctor if any side effects become annoying or not disappear.

Fox News Digital connect to Vertex for an additional comment.

Leave a Reply

Your email address will not be published. Required fields are marked *